To examine the lytic activity of immune T cells in relation to the 3 metabolic subtypes, we used the average expression levels of GZMA and PRF1 [26] to determine the level of lytic activity exhibited by immune T cells in each patient's tumor. This evidence concerns the gene PRF1 and neoplasm.